🎁 Black Friday: up to 50% off of annual plans
Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.25
-0.35 (-1.18%)
Nov 20, 2026, 1:30 PM CST

Taiyen Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,2003,3083,2383,4093,6144,096
Revenue Growth
-2.24%2.15%-5.01%-5.67%-11.77%30.84%
Cost of Revenue
1,9671,9651,9172,1512,3372,722
Gross Profit
1,2321,3411,3211,2571,2771,373
Selling, General & Admin
805.99821.75835.39801.98770.92786.46
Research & Development
54.0454.7854.7160.560.6457.6
Operating Expenses
815.18866.87966.37936.04831.56844.06
Operating Income
416.34474.19354.54321.44445.05529.18
Interest Expense
-4.7-3.72-6.34-3.35-4.52-5.94
Interest & Investment Income
26.3526.3537.9335.9317.8810.66
Currency Exchange Gain (Loss)
-16.74-16.7438.54-5.6758.69-20.59
Other Non Operating Income (Expenses)
53.9929.312.99-21.2620.651.93
EBT Excluding Unusual Items
475.24509.38427.66327.1537.74515.23
Gain (Loss) on Sale of Investments
7.617.6112.857.43-0.36-0.54
Gain (Loss) on Sale of Assets
-0.48-0.48-1.04-1.28-1.28-1.24
Other Unusual Items
-22.54-22.54-6.44-4.13-5.52-3.54
Pretax Income
459.82493.97433.03329.12530.59509.92
Income Tax Expense
83.06100.28115.58111.82103.0797.76
Earnings From Continuing Operations
376.76393.69317.45217.3427.52412.16
Minority Interest in Earnings
-6.1854.0783.09-0.81-18.94
Net Income
376.76399.87371.52300.39426.7393.23
Net Income to Common
376.76399.87371.52300.39426.7393.23
Net Income Growth
12.99%7.63%23.68%-29.60%8.51%7.71%
Shares Outstanding (Basic)
199200200200200200
Shares Outstanding (Diluted)
200201201200201201
Shares Change
-0.39%0.04%0.06%-0.08%0.05%-
EPS (Basic)
1.892.001.861.502.131.97
EPS (Diluted)
1.881.991.851.502.131.96
EPS Growth
13.30%7.57%23.33%-29.58%8.67%7.69%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
331.5131.89352.51112.89334.58211.29
Free Cash Flow Per Share
1.660.661.760.561.671.05
Dividend Per Share
1.4001.4001.3001.2001.5001.500
Dividend Growth
7.69%7.69%8.33%-20.00%0%11.11%
Gross Margin
38.48%40.54%40.79%36.89%35.33%33.53%
Operating Margin
13.01%14.34%10.95%9.43%12.32%12.92%
Profit Margin
11.77%12.09%11.47%8.81%11.81%9.60%
Free Cash Flow Margin
10.36%3.99%10.89%3.31%9.26%5.16%
EBITDA
669.59710.17561.57508.88628.74707.81
EBITDA Margin
20.92%21.47%17.34%14.93%17.40%17.28%
D&A For EBITDA
253.25235.98207.03187.44183.69178.64
EBIT
416.34474.19354.54321.44445.05529.18
EBIT Margin
13.01%14.34%10.95%9.43%12.32%12.92%
Effective Tax Rate
18.06%20.30%26.69%33.98%19.43%19.17%